Andrew Harold Hull

Andrew Harold Hull discloses dealings in InMed Pharmaceuticals Inc. to SEC (Form 4). The record holds 4 filings, for trades running from 30 June 2020 to 14 November 2024.

Purchases make up the whole of the open-market record (1 purchase, €9,998). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at 1 purchase and no sales.

The newest entry dates from 22 December 2024: a transaction, in InMed Pharmaceuticals Inc. The last purchase on record was published on 22 February 2024, which is 992 days ago. Typically, a trade is published a median of 37 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.